Evidence map›Paper›PMID 35358476›Full record

ArticleThe American journal of pathology2022

Barrier-Forming Potential of Epithelial Cells from the Exstrophic Bladder.

Jennifer Hinley, Rosalind Duke, Jessica Jinks, Jens Stahlschmidt, David Keene, Raimondo M Cervellione, Imran Mushtaq, Paolo De Coppi, Massimo Garriboli, Jennifer Southgate

Open access · hybridAbstract read
In one paragraph

Article in The American journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jennifer HinleyJack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, United Kingdom.
Rosalind DukeJack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, United Kingdom.
Jessica JinksJack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, United Kingdom.
Jens StahlschmidtJack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, United Kingdom; Department of Histopathology, St James's University Hospital, Leeds, United Kingdom.
David KeeneDepartment of Paediatric Urology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
Raimondo M CervellioneDepartment of Paediatric Urology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
Imran MushtaqDepartment of Paediatric Urology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.
Paolo De CoppiDepartment of Paediatric Urology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom; National Institute for Health and Care Research Biomedical Research Centre, University College London Great Ormond Street Institute of Child Health, London, United Kingdom. Electronic address: p.decoppi@ucl.ac.uk.
Massimo GarriboliNational Institute for Health and Care Research Biomedical Research Centre, University College London Great Ormond Street Institute of Child Health, London, United Kingdom; Paediatric Urology, Evelina London Children's Hospital, London, United Kingdom.
Jennifer SouthgateJack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, United Kingdom. Electronic address: j.southgate@york.ac.uk.
University of York · GBNational Health Service · GBRoyal Manchester Children's Hospital · GBGreat Ormond Street Hospital · GBSt James's University Hospital · GB

Funding

Department of HealthMedical Research Council MR/L013347/1Medical Research Council MR/N028414/1
6 · The paper itself

Abstract

Bladder exstrophy (BEX) is a rare developmental abnormality resulting in an open, exposed bladder plate. Although normal bladder urothelium is a mitotically quiescent barrier epithelium, histologic studies of BEX epithelia report squamous and proliferative changes that can persist beyond surgical closure. The current study examined whether patient-derived BEX epithelial cells in vitro were capable of generating a barrier-forming epithelium under permissive conditions. Epithelial cells isolated from 11 BEX samples, classified histologically as transitional (n = 6) or squamous (n = 5), were propagated in vitro. In conditions conducive to differentiated tight barrier formation by normal human urothelial cell cultures, 8 of 11 BEX lines developed transepithelial electrical resistances of more than 1000 Ω.cm

Indexed as

Carcinoma, Squamous CellUrinary BladderCell DifferentiationEpithelial CellsHumansUrothelium

Identifiers

PMID35358476
PMCPMC9194657
OpenAlexW4220895127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.